The top 5 biosimilar articles touch on the growing biosimilar landscape, including recent FDA approvals, patent disputes, ...

While treatment options may be fairly straightforward for high-risk patients with polycythemia vera, it’s less clear for ...

In 2024, multiple drugs received complete response letters (CRLs), sometimes unrelated to the safety and efficacy of the drug ...

The most-read articles focused on the new colonoscopy guidelines, the relationship between diabetes and colorectal cancer, ...

Advances in therapy are improving outcomes for patients, but the incidence and mortality rates for hepatocellular carcinoma ...

This year’s most-read articles on chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) explored treatment ...

Check out this year's top coverage from The Academy of Managed Care Pharmacy (AMCP) Nexus 2024 meeting, which included ...

The top 5 most-viewed videos of 2024 highlighted advancements in therapies, heart disease screening, pediatric palliative ...

A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton ...

There are a number of considerations both in the short and long term to consider when making treatment decisions for younger ...

The top content from the Institute for Value-Based Medicine® (IVBM®) highlighted innovative approaches to improving care ...

This year's top 5 most-read cardiovascular articles explored topics ranging from FDA approvals to the risks associated with ...